REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zuellig Pharma Specialty Solutions Group Pte. Ltd. (Singapore)

Main Activities: All Other Miscellaneous Manufacturing
Secondary Activities: Refrigerated Warehousing and Storage
Full name: Zuellig Pharma Specialty Solutions Group Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: other manufacturing industries n.e.c.; Secondary Business Activity: refrigerated warehousing and storage (bio-logistics services division offering customized & value-added solutions)

Headquarters
15 Changi North Way, #01-01, Singapore
Singapore; Singapore; Postal Code: 498770

Contact Details: Purchase the Zuellig Pharma Specialty Solutions Group Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Zuellig Pharma Specialty Solutions Group Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Zuellig Pharma Specialty Solutions Group Pte. Ltd. report to view the information.
Incorporation Date:
May 04, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Zuellig Pharma Specialty Solutions Group Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
39.42%▲
Total operating revenue
39.42%▲
Net Profit (Loss) for the Period
32.03%▲
Total assets
17.21%▲
Total equity
46.27%▲
Net Profit Margin
-0.94%▼
Return on Equity (ROE)
-6.17%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo